{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:08:26Z","timestamp":1790096906239,"version":"4.0.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T00:00:00Z","timestamp":1511395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Aegerion"},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]},{"name":"IONIS"},{"name":"Akcea Therapeutics"},{"DOI":"10.13039\/100007560","name":"Chiesi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009857","name":"Regeneron","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.numecd.2017.11.001","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T19:45:17Z","timestamp":1510602317000},"page":"197-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3786-0883","authenticated-orcid":false,"given":"M.","family":"Arca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1238-872X","authenticated-orcid":false,"given":"R.","family":"Pontremoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.M.","family":"De Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Colivicchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0145-1271","authenticated-orcid":false,"given":"G.","family":"Desideri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.L.","family":"Temporelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.numecd.2017.11.001_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00043798-199604000-00014","article-title":"Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies","volume":"3","author":"Hokanson","year":"1996","journal-title":"J Cardiovasc Risk"},{"issue":"4","key":"10.1016\/j.numecd.2017.11.001_bib2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.numecd.2017.11.001_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/HCO.0b013e32832c1284","article-title":"Triglycerides as vascular risk factors: new epidemiologic insights","volume":"24","author":"Kannel","year":"2009","journal-title":"Curr Opin Cardiol"},{"issue":"6","key":"10.1016\/j.numecd.2017.11.001_bib4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia\u2013current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"24","key":"10.1016\/j.numecd.2017.11.001_bib5","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehs431","article-title":"Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction","volume":"34","author":"Jorgensen","year":"2013","journal-title":"Eur Heart J"},{"issue":"9726","key":"10.1016\/j.numecd.2017.11.001_bib6","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.numecd.2017.11.001_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.numecd.2017.11.001_bib8","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.numecd.2017.11.001_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/07315724.2001.10719008","article-title":"Types of dietary fat and risk of coronary heart disease: a critical review","volume":"20","author":"Hu","year":"2001","journal-title":"J Am Coll Nutr"},{"issue":"8","key":"10.1016\/j.numecd.2017.11.001_bib10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.numecd.2017.11.001_bib11","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/clinchem\/39.6.1012","article-title":"Biological variability in concentrations of serum lipids: sources of variation among results from published studies and composite predicted values","volume":"39","author":"Smith","year":"1993","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.numecd.2017.11.001_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1373\/clinchem.2007.098863","article-title":"Fasting versus nonfasting triglycerides: implications for laboratory measurements","volume":"54","author":"Warnick","year":"2008","journal-title":"Clin Chem"},{"issue":"Suppl. 1","key":"10.1016\/j.numecd.2017.11.001_bib13","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.2459\/JCM.0000000000000438","article-title":"How important are triglycerides as risk factors?","volume":"18","author":"D'Addato","year":"2017","journal-title":"J Cardiovasc Med"},{"issue":"18","key":"10.1016\/j.numecd.2017.11.001_bib14","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1001\/jama.2008.621","article-title":"Nonfasting triglycerides and risk of ischemic stroke in the general population","volume":"300","author":"Freiberg","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.numecd.2017.11.001_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","author":"Jorgensen","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.numecd.2017.11.001_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"issue":"39","key":"10.1016\/j.numecd.2017.11.001_bib17","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2017.11.001_bib18","series-title":"Endotext","article-title":"Introduction to lipids and lipoproteins","author":"Feingold","year":"2015"},{"issue":"1","key":"10.1016\/j.numecd.2017.11.001_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2009.12.027","article-title":"The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight","volume":"211","author":"Dallinga-Thie","year":"2010","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.numecd.2017.11.001_bib20","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"CMAJ"},{"issue":"9","key":"10.1016\/j.numecd.2017.11.001_bib21","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2017.0972","article-title":"Association of rare and common variation in the lipoprotein lipase gene with coronary artery disease","volume":"317","author":"Khera","year":"2017","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.numecd.2017.11.001_bib22","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","article-title":"Inactivating variants in ANGPTL4 and risk of coronary artery disease","volume":"374","author":"Dewey","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.numecd.2017.11.001_bib23","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1507652","article-title":"Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease","volume":"374","author":"Stitziel","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.numecd.2017.11.001_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2337\/diacare.4.3.343","article-title":"Chylomicronemia syndrome in diabetes mellitus","volume":"4","author":"Chait","year":"1981","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.numecd.2017.11.001_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.numecd.2011.09.007","article-title":"Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis","volume":"22","author":"Fogelstrand","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2017.11.001_bib26","series-title":"Detection, evaluation and treatment high blood cholesterol in adults (Adult Treatment Panel III)","author":"National Cholesterol Education Program (NCEP) Expert Panel","year":"2002"},{"issue":"7","key":"10.1016\/j.numecd.2017.11.001_bib27","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jacc.2007.10.038","article-title":"Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial","volume":"51","author":"Miller","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.numecd.2017.11.001_bib28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2017.11.001_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12937-015-0009-0","article-title":"Postprandial triglyceride response in normolipidemic, hyperlipidemic and obese subjects - the influence of polydextrose, a non-digestible carbohydrate","volume":"14","author":"Tiihonen","year":"2015","journal-title":"Nutr J"},{"issue":"5","key":"10.1016\/j.numecd.2017.11.001_bib30","doi-asserted-by":"crossref","first-page":"e96297","DOI":"10.1371\/journal.pone.0096297","article-title":"Hypertriglyceridemia influences the degree of postprandial lipemic response in patients with metabolic syndrome and coronary artery disease: from the CORDIOPREV study","volume":"9","author":"Alcala-Diaz","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.numecd.2017.11.001_bib31","first-page":"282","article-title":"Proatherogenic role of elevated CE transfer from HDL to VLDL1 and dense LDL in type 2 diabetes","volume":"21","author":"Gu\u00e9rin","year":"2001","journal-title":"Impact Degree Triglyceridemia"},{"key":"10.1016\/j.numecd.2017.11.001_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12933-014-0159-y","article-title":"Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor","volume":"13","author":"Tenenbaum","year":"2014","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"10.1016\/j.numecd.2017.11.001_bib33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.7326\/0003-4819-150-7-200904070-00007","article-title":"Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes","volume":"150","author":"Ip","year":"2009","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.numecd.2017.11.001_bib34","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12325-016-0462-y","article-title":"A review of clinical practice guidelines for the management of hypertriglyceridemia: a focus on high dose omega-3 fatty acids","volume":"34","author":"Karalis","year":"2017","journal-title":"Adv Ther"},{"issue":"4","key":"10.1016\/j.numecd.2017.11.001_bib35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.amjcard.2009.04.008","article-title":"Plasma triglycerides and cardiovascular events in the treating to new targets and incremental decrease in end-points through aggressive lipid lowering trials of statins in patients with coronary artery disease","volume":"104","author":"Faergeman","year":"2009","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.numecd.2017.11.001_bib36","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jacc.2010.09.073","article-title":"The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals","volume":"57","author":"Kastorini","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.numecd.2017.11.001_bib37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cardiores.2006.08.019","article-title":"Cardiovascular benefits of omega-3 fatty acids","volume":"73","author":"von Schacky","year":"2007","journal-title":"Cardiovasc Res"},{"issue":"15","key":"10.1016\/j.numecd.2017.11.001_bib38","doi-asserted-by":"crossref","first-page":"e867","DOI":"10.1161\/CIR.0000000000000482","article-title":"Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the American Heart Association","volume":"135","author":"Siscovick","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.numecd.2017.11.001_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jacc.2004.10.031","article-title":"Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials","volume":"45","author":"Birjmohun","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.numecd.2017.11.001_bib40","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.atherosclerosis.2011.04.020","article-title":"Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: a meta-analysis","volume":"217","author":"Lee","year":"2011","journal-title":"Atherosclerosis"},{"issue":"6A","key":"10.1016\/j.numecd.2017.11.001_bib41","doi-asserted-by":"crossref","first-page":"3C","DOI":"10.1016\/j.amjcard.2006.11.016","article-title":"Safety considerations with fibrate therapy","volume":"99","author":"Davidson","year":"2007","journal-title":"Am J Cardiol"},{"issue":"14","key":"10.1016\/j.numecd.2017.11.001_bib42","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.numecd.2017.11.001_bib43","first-page":"681","article-title":"Overview of omega-3 fatty acid therapies","volume":"38","author":"Bradberry","year":"2013","journal-title":"P T"},{"issue":"5","key":"10.1016\/j.numecd.2017.11.001_bib44","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bbalip.2011.10.011","article-title":"Fish oil \u2013 how does it reduce plasma triglycerides?","volume":"1821","author":"Shearer","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"10.1016\/j.numecd.2017.11.001_bib45","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0022-2275(20)38424-8","article-title":"Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids","volume":"29","author":"Harris","year":"1988","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.numecd.2017.11.001_bib46","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.atherosclerosis.2012.09.002","article-title":"Effects of omega-3 fatty acids on postprandial triglycerides and monocyte activation","volume":"225","author":"Schirmer","year":"2012","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.numecd.2017.11.001_bib47","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.biopha.2014.10.008","article-title":"Omega-3 fatty acids improve postprandial lipemia and associated endothelial dysfunction in healthy individuals - a randomized cross-over trial","volume":"68","author":"Miyoshi","year":"2014","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"10.1016\/j.numecd.2017.11.001_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071552","article-title":"Enriching diet with n-3 PUFAs to help prevent cardiovascular diseases in healthy adults: results from clinical trials","volume":"18","author":"Manuelli","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.numecd.2017.11.001_bib49","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11883-011-0210-3","article-title":"Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis","volume":"13","author":"Wei","year":"2011","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"10.1016\/j.numecd.2017.11.001_bib50","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12944-016-0286-4","article-title":"The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia","volume":"15","author":"Backes","year":"2016","journal-title":"Lipids Health Dis"},{"issue":"5","key":"10.1016\/j.numecd.2017.11.001_bib51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00000441-200211000-00003","article-title":"Eicosapentaenoic acid improves endothelial function in hypertriglyceridemic subjects despite increased lipid oxidizability","volume":"324","author":"Okumura","year":"2002","journal-title":"Am J Med Sci"},{"issue":"12","key":"10.1016\/j.numecd.2017.11.001_bib52","doi-asserted-by":"crossref","first-page":"672","DOI":"10.5414\/CPP42672","article-title":"Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study","volume":"42","author":"Engler","year":"2004","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.numecd.2017.11.001_bib53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000329300","article-title":"Early impact of prescription omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia","volume":"118","author":"Serebruany","year":"2011","journal-title":"Cardiology"},{"issue":"9","key":"10.1016\/j.numecd.2017.11.001_bib54","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1194\/jlr.P024315","article-title":"Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects","volume":"53","author":"Ooi","year":"2012","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.numecd.2017.11.001_bib55","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/jn\/134.5.1051","article-title":"A solid dietary fat containing fish oil redistributes lipoprotein subclasses without increasing oxidative stress in men","volume":"134","author":"Tholstrup","year":"2004","journal-title":"J Nutr"},{"issue":"4","key":"10.1016\/j.numecd.2017.11.001_bib56","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1203859","article-title":"n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia","volume":"367","author":"Bosch","year":"2012","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.numecd.2017.11.001_bib57","article-title":"Effects of omega-3 fatty acid supplementation on glucose control and lipid levels in type 2 diabetes: a meta-analysis","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"issue":"9567","key":"10.1016\/j.numecd.2017.11.001_bib58","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"issue":"9177","key":"10.1016\/j.numecd.2017.11.001_bib59","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico","volume":"354","year":"1999","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.numecd.2017.11.001_bib60","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1003603","article-title":"n-3 fatty acids and cardiovascular events after myocardial infarction","volume":"363","author":"Kromhout","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2017.11.001_bib61","doi-asserted-by":"crossref","first-page":"c6273","DOI":"10.1136\/bmj.c6273","article-title":"Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial","volume":"341","author":"Galan","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.numecd.2017.11.001_bib62","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ajcn\/74.1.50","article-title":"Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol","volume":"74","author":"Nilsen","year":"2001","journal-title":"Am J Clin Nutr"},{"issue":"21","key":"10.1016\/j.numecd.2017.11.001_bib63","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1161\/CIRCULATIONAHA.110.948562","article-title":"OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction","volume":"122","author":"Rauch","year":"2010","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.numecd.2017.11.001_bib64","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1205409","article-title":"n-3 fatty acids in patients with multiple cardiovascular risk factors","volume":"368","author":"Roncaglioni","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.numecd.2017.11.001_bib65","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1023\/A:1007757724505","article-title":"Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival\u20134","volume":"11","author":"Singh","year":"1997","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"10.1016\/j.numecd.2017.11.001_bib66","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2215\/CJN.00630206","article-title":"N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial","volume":"1","author":"Svensson","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.numecd.2017.11.001_bib67","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/jamainternmed.2014.328","article-title":"Effect of long-chain \u03c9-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial","volume":"174","author":"Bonds","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.numecd.2017.11.001_bib68","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1567-5688(13)70005-9","article-title":"Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: a meta-analysis of randomized, placebo controlled trials [corrected]","volume":"14","author":"Casula","year":"2013","journal-title":"Atheroscler Suppl"},{"issue":"5","key":"10.1016\/j.numecd.2017.11.001_bib69","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.numecd.2013.12.004","article-title":"Effects of omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: a meta-analysis of randomized controlled trials","volume":"24","author":"Wen","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.numecd.2017.11.001_bib70","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.amjcard.2015.10.050","article-title":"Effects of polyunsaturated fatty acid treatment on postdischarge outcomes after acute myocardial infarction","volume":"117","author":"Greene","year":"2016","journal-title":"Am J Cardiol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475317302685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475317302685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T21:44:12Z","timestamp":1668721452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475317302685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0939475317302685"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2017.11.001","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2017.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}